IRS1 and Insulin resistance: It not only improves glycemic control via PI3K/Akt and IRS1 restoration, but also blocks NF-κB-mediated inflammation, decreasing expression of TNF-α and IL-6—two upstream drivers of adipose and hepatic insulin resistance [104,105].